comparison of the effectiveness of Modafinil and methylphenidate in treatment of excessive daytime sleepiness in patients with Parkinson disease
Phase 3
Recruiting
- Conditions
- Daily-time sleepiness in patients with Parkinson's.Parkinson's disease
- Registration Number
- IRCT20220623055257N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients who have Parkinson disease
diagnosis of excessive daytime sleepiness(EDS) by neurologist
not having sensitivity to Modafinil or Methylphenidate
Individual consent to participate in the study
Exclusion Criteria
Dissatisfaction of the patient to continue participating in the study
history of head trauma
diagnosis of other neurological disease such as Dementia
thyroid disorder
history of CVA
drug abuser
kidney or liver failure
heart disease
History of a psychiatric illness being treated with psychiatric medication
Taking hypnotics
being illiterate
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Daily sleepiness in patients with Parkinson's. Timepoint: Beginning of study and 8 weeks later. Method of measurement: Epworth Questionnaire.
- Secondary Outcome Measures
Name Time Method